Browsing by Autor "Roberto Polanco-Carrasco"

Now showing 1 - 7 of 7

COVID-19 anxiety, psychological well-being and preventive behaviors during the COVID-19 pandemic in Latin America and the Caribbean: relationships and explanatory model
(Springer Science+Business Media, 2022) Tomás Caycho‐Rodríguez; José M. Tomás; Pablo D. Valencia; José Ventura‐León; Lindsey W. Vilca; Carlos Carbajal‐León; Mario Reyes-Bossio; Michaël White; Claudio Rojas-Jara; Roberto Polanco-Carrasco
Cross-Cultural Validation of a New Version in Spanish of Four Items of the Preventive COVID-19 Infection Behaviors Scale (PCIBS) in Twelve Latin American Countries
(Frontiers Media, 2021) Tomás Caycho‐Rodríguez; Lindsey W. Vilca; Pablo D. Valencia; Carlos Carbajal‐León; Andrea Vivanco-Vidal; Daniela Saroli-Araníbar; Mario Reyes-Bossio; Michaël White; Claudio Rojas-Jara; Roberto Polanco-Carrasco
The invariance of the Preventive COVID-19 Infection Behaviors Scale (PCIBS) was evaluated in 12 Latin American countries (Argentina, Bolivia, Chile, Colombia, Cuba, Ecuador, El Salvador, Guatemala, Mexico, Paraguay, Peru, and Uruguay). A total of 5183 people from the aforementioned countries participated, selected using the snowball sampling method. Measurement invariance was assessed by multigroup confirmatory factor analysis (MG-CFA) and Multi-Group Factor Analysis Alignment (CFA-MIAL). In addition, item characteristics were assessed based on Item Response Theory. The results indicate that the original five-item version of the PCIBS is not adequate; whereas a four-item version of the PCIBS (PCIBS-4) showed a good fit in all countries. Thus, using the MG-CFA method, the PCIBS-4 achieved metric invariance, while the CFA-MIAL method indicated that the PCIBS-4 shows metric and scalar invariance. Likewise, the four items present increasing difficulties and high values in the discrimination parameters. The comparison of means of the PCIBS-4 reported irrelevant differences between countries; however, Mexico and Peru presented the highest frequency of preventive behaviors related to COVID-19. It is concluded that the PCIBS-4 is a unidimensional self-report measure which is reliable and invariant across the twelve participating Latin American countries. It is expected that the findings will be of interest to social and health scientists, as well as those professionals directly involved in public health decision making.
Cross-cultural validation of the new version of the Coronavirus Anxiety Scale in twelve Latin American countries
(Springer Science+Business Media, 2022) Tomás Caycho‐Rodríguez; Pablo D. Valencia; Lindsey W. Vilca; Carlos Carbajal‐León; Andrea Vivanco-Vidal; Daniela Saroli-Araníbar; Mario Reyes-Bossio; Michaël White; Claudio Rojas-Jara; Roberto Polanco-Carrasco
Design and Cross-Cultural Invariance of the COVID-19 Vaccine Conspiracy Beliefs Scale (COVID-VCBS) in 13 Latin American Countries
(Frontiers Media, 2022) Tomás Caycho‐Rodríguez; Pablo D. Valencia; José Ventura‐León; Lindsey W. Vilca; Carlos Carbajal‐León; Mario Reyes-Bossio; Michaël White; Claudio Rojas-Jara; Roberto Polanco-Carrasco; Miguel Gallegos
The results allow for improved understanding of conspiracy beliefs about COVID-19 vaccines in the countries assessed; furthermore, they provide researchers and practitioners with an invariant measure that they can use in cross-cultural studies in Latin America. However, further studies are needed to test invariance in other countries, with the goal of developing a truly international measure of conspiracy beliefs about COVID-19 vaccines.
Network analysis of the relationships between conspiracy beliefs towards COVID-19 vaccine and symptoms of fear of COVID-19 in a sample of latin american countries
(Springer Science+Business Media, 2022) Tomás Caycho‐Rodríguez; José Ventura‐León; Pablo D. Valencia; Lindsey W. Vilca; Carlos Carbajal‐León; Mario Reyes-Bossio; Mariel Delgado-Campusano; Claudio Rojas-Jara; Roberto Polanco-Carrasco; Miguel Gallegos
Prevalence and Predictors of Intention to be Vaccinated Against COVID-19 in Thirteen Latin American and Caribbean Countries
(Springer Science+Business Media, 2022) Tomás Caycho‐Rodríguez; Pablo D. Valencia; Lindsey W. Vilca; Carlos Carbajal‐León; Andrea Vivanco-Vidal; Daniela Saroli-Araníbar; Mario Reyes-Bossio; Michaël White; Claudio Rojas-Jara; Roberto Polanco-Carrasco
What Is the Support for Conspiracy Beliefs About COVID-19 Vaccines in Latin America? A Prospective Exploratory Study in 13 Countries
(Frontiers Media, 2022) Tomás Caycho‐Rodríguez; José Ventura‐León; Pablo D. Valencia; Lindsey W. Vilca; Carlos Carbajal‐León; Mario Reyes-Bossio; Michaël White; Claudio Rojas-Jara; Roberto Polanco-Carrasco; Miguel Gallegos
Conspiracy theories about COVID-19 began to emerge immediately after the first news about the disease and threaten to prolong the negative impact of the COVID-19 pandemic by limiting people's willingness of receiving a life-saving vaccine. In this context, this study aimed to explore the variation of conspiracy beliefs regarding COVID-19 and the vaccine against it in 5779 people living in 13 Latin American countries (Argentina, Bolivia, Chile, Colombia, Cuba, Ecuador, El Salvador, Guatemala, Mexico, Paraguay, Peru, Uruguay and Venezuela) according to sociodemographic variables such as gender, age, educational level and source of information about COVID-19. The study was conducted during the COVID-19 pandemic between September 15 and October 25, 2021. The Spanish-language COVID-19 Vaccine Conspiracy Beliefs Scale (ECCV-COVID) and a sociodemographic survey were used. The results indicate that, in most countries, women, people with a lower educational level and those who receive information about the vaccine and COVID-19 from family/friends are more supportive of conspiracy ideas regarding the COVID-19 vaccine. In the case of age, the results vary by country. The analysis of the responses to each of the questions of the ECCV-COVID reveals that, in general, the countries evaluated are mostly in some degree of disagreement or indecision regarding conspiratorial beliefs about COVID-19 vaccines. The findings could help open further study which could support prevention and treatment efforts during the COVID-19 pandemic.